Q&A: MPI's Hans Lehrach on Combining Deep Sequencing and Predictive Models to Improve Cancer Therapy | GenomeWeb

HansLehrach2_0.jpgName: Hans Lehrach
Age: 62
Position: Director, Max Planck Institute for Molecular Genetics, Berlin; head of Department of Vertebrate Genomics, since 1994
Experience and Education:
Head of Department of Genome Analysis, Imperial Cancer Research Fund, London, 1987-1994

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.